Introduction
Disruption of neurological structure by injuries to the spinal cord reduces personal motion ability or can lead to paraplegia and death. The CNS can heal and regenerate axons, but the rate is very slow and cannot stop myelin sheath degeneration and cell death especially in the second stage of injury [1] . The limited nature of repair results in functional recovery is being more sporadic than organized. Cell therapy and tissue engineering could provide a therapeutic approach to CNS regeneration [1] [2] . Different cells from various sources under different in vivo condition have been investigated [3] . Tissue engineering provides alternative way for CNS regeneration using cellular transplantation and biomaterial scaffolds [4] .
The human endometrial is a dynamic tissue, which undergoes cycles of growth and regression with each menstrual cycle. It is likely that adult stem/progenitor cells are responsible for this remarkable regenerative capacity [5] [6] . It was demonstrated that human endometrium contains a low number of endometrial stem cells which seem to belong to the family of the mesenchymal stem cells [7] [8] . Previous studies have shown the potential differentiation of the endometrial stem cells into chondrogenic and osteoblastic lineages when cultured in appropriate induction medium [9] - [11] . In addition, other studies have shown that stromal cells from endometrial explants can proliferate and then generate new vessels [12] [13] . Since endometrial stromal cells are easy to isolate, and expand rapidly from patients without leading to major ethical and technical problems. Moreover, EnSCs plasticity has been proven by their differentiation along other lineage, such as osteoblast, adipocytes, cardiomyocytes, neuronal, and oligodendrocyte cells [14] - [17] . Therefore, endometrium may be an alternative source of MSC-like cells for tissue engineering purposes, obtainable with no extra morbidity than that required for other sources of stem cells [18] . Nerve injury involves the response of Schwann cells (SCs), the glial cells of the peripheral nervous system, due to remodeling of SC phenotype, and eventually aids the outgrowing axon to reach the target of reinnervation [19] - [21] . For these reasons, SCs were the first cells to be transplanted in bioengineered nerve grafts, thereby improving nerve regeneration; Schwann cells are fundamental for development, myelination and regeneration in the peripheral nervous system [22] - [24] . Slow growth rate and difficulties in harvesting limit SC applications in regenerative medicine [23] [24] . It was shown that various stem cells such as mesenchymal stem cells/marrow stromal stem cells (MSC) and adipose-derived stem cells (ADSC-SCs) had the potential to differentiate into the Schwann cells [25] [26] .
In this study, endometrial stromal cells were used as a new source for differentiation to Schwann cells. They were isolated from the donor's tissue; Schwann cells derived from these cells were cultured in fibrin gel. Fibrin has a long history in tissue engineering applications, especially in wound healing. It is a naturally occurring clotting agent in human body, so it has a highly biocompatible scaffold and is easily degraded by enzymes inside the body. Mechanical and chemical properties of this hydrogel can be adjusted by simply changing fibrinogen concentration; also there is an enzymatic crosslinking mechanism that can be easily and harmlessly injected [27] .
Hypothesis
Stem cell therapy has been suggested as a novel treatment for the management of neurodegenerative diseases. The previous studies demonstrated that the pluripotent embryonic stem cells and adult stem cells are capable of differentiating into Schwann cell types which express Schwann-related proteins [28] .
Recently, stem cells were isolated from human endometrium, using Schwann differentiation medium. Herein, we postulate that because of the outcome and complication of the other sources of stem cells, stem cell therapy through application of endometrial stem cells can open a new horizon for the treatment of neurodegenerative disorders with lesser degree of complications and better efficacy and outcome [29] .
Evaluation of the Hypothesis
The hypothesis can be evaluated by using flow cytometery for detection of stem cell markers such asCD146, CD90 in the isolated endometrial stem cells. Also, isolated stromal cells will be examined to be free from hematopoietic cells using CD34 staining. The next step is to investigate the ability of human endometrial adult stem cells to differentiate into the Schwann cells showing characteristics of Schwann-like cells (Figure 1) . For this purpose, the endometrial stem cells will be induced by Schwann cell differentiation medium. Subsequently, immunocytochemistry will be used for the confirmation of Schwann markers expression such as S100 and P75 in the differentiated cells. Multipotent adult stem/progenitor cells in the endometrium are characterized by a remarkable regenerative capacity of undergoing repetitive cycles of growth and differentiation. Endometrial regenerative cells possess the potential to differentiate into adipocytes, endothelial cells, pancreatic cells and neurons [30] . According previous invaluable experiments, EnSCs have a great potential to differentiate into adipocytes, osteoblasts as well as neurons, and these cells are capable of generating odontoblasts as well as myoblast cells [31] [32] . Thus, it is hypothesized that endometrial adult stem (stromal) cells, could be novel candidates for derivation of Schwann cells, and provide an attractive alternative resource for Schwann cells therapies.
Discussion
Surgical repair of the peripheral nerve injuries is a frequent clinical problem. For larger nerve defects, transplantation of a nerve graft is often necessary to facilitate nerve regeneration and functional improvement. Alternatives to conventional auto grafts have long been sought because of some problems associated with auto grafts, and the emergence of tissue engineering has greatly stimulated the development of the artificial nerve grafts. It was indicated that the endometrial stem cells displaying excellent multipotent potential [33] .
However, the baseline colony forming ability of the endometrial stromal cells is comparable to most enriched bone marrow MSC populations [34] [35] . Endometrial stromal cells can be obtained by a simple, safe and painless procedure in contrast to bone marrow aspiration. These cells have higher clonogenicity and can be obtained from elderly donors because other cell source such as bone marrow MSCs loss their differentiation capacity significantly with increased donor age. It may be concluded that the endometrial stem cells in the treatment of neuronal disorders are more convenient than other sources of stem cells.
Conclusion
In the past few years, for neurodegenerative diseases therapy, research has focused on the stem cells therapy. Due to promising results in stem cell therapy, there are different sources of stem cells for transplantation in human. Recently, a highly promising source of accessible, abundant and multipotent adult stem cells is human endometrial stem cells. Consequently, we hypothesize that endometrial adult stem cells can differentiate into Schwann cells when they are exposed to specific differentiated conditions. These stem cells have potential advantages over other stem cells and are attractive candidate for nervous system regeneration.
